VOGX — Vogenx, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1903784 ·
Last close
$29.52
Market Cap
—
52W High
$29.64
52W Low
$12.95
ADV30
342,650
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -463,153 | -475,452 | 898,459 | 250,753 | 2,297,998 |
| Mar 2025 | 0 | — | -372,198 | -356,619 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-738,248
Investing CF
—
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-08-11
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,439,118 | -1,445,603 | 681,170 | 1,600,405 | — | -1,111,913 |
| Dec 2024 | 0 | -2,300,834 | -2,203,591 | 970,398 | 460,814 | — | -2,341,372 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.12T | $1255.40 | — |
| JNJ | JOHNSON & JOHNSON | $651.25B | $270.24 | — |
| ABBV | AbbVie Inc. | $468.22B | $264.96 | — |
| MRK | Merck & Co., Inc. | $376.37B | $152.55 | — |
| NVS | NOVARTIS AG | $301.95B | $158.86 | — |
News headlines (Yahoo Finance, 1h cache)
Jones Served as Sole Book-Running Manager for Vogenx's $81.3 Million Initial Public Offering
2026-08-17 16:25 · Yahoo
Vogenx Announces Closing of Initial Public Offering
2026-08-13 20:35 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.